US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 12.920
  • -0.160-1.22%
Close Sep 27 16:00 ET
  • 12.920
  • 0.0000.00%
Post 16:01 ET
2.07BMarket Cap-7537P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
51.73%63.82M
53.38%60.07M
85.54%252.1M
271.13%114M
85.82%56.86M
34.32%42.06M
-9.41%39.17M
-42.75%135.87M
15.71%30.72M
-82.82%30.6M
Selling and administrative expenses
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
89.53%15.26M
19.36%9.29M
19.74%9.68M
26.78%31.12M
-5.80%7.2M
20.90%8.05M
-General and administrative expense
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
89.53%15.26M
19.36%9.29M
19.74%9.68M
26.78%31.12M
-5.80%7.2M
20.90%8.05M
Research and development costs
48.40%48.63M
55.19%45.76M
97.26%206.62M
336.88%102.77M
84.49%41.6M
39.28%32.77M
-16.11%29.49M
-50.77%104.75M
24.40%23.52M
-86.85%22.55M
Operating profit
-51.73%-63.82M
-53.38%-60.07M
-85.54%-252.1M
-271.13%-114M
-85.82%-56.86M
-34.32%-42.06M
9.41%-39.17M
42.75%-135.87M
-15.71%-30.72M
82.82%-30.6M
Net non-operating interest income expense
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
172.97%3.84M
353.83%3.56M
4,050.00%3.57M
4.56M
2.29M
1.41M
Non-operating interest income
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
172.97%3.84M
353.83%3.56M
4,050.00%3.57M
--4.56M
--2.29M
--1.41M
Other net income (expense)
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
99.32%-1K
-124.68%-39K
-124.07%-26K
3,581.82%405K
168.01%287K
-243.69%-148K
Other non- operating income (expenses)
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
99.32%-1K
-124.68%-39K
-124.07%-26K
3,581.82%405K
168.01%287K
-243.69%-148K
Income before tax
-51.97%-58.58M
-50.80%-53.72M
-80.02%-235.66M
-285.35%-108.46M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
Income tax
125K
268K
0
0
Net income
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
Net income continuous Operations
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
Minority interest income
Net income attributable to the parent company
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
83.52%-29.34M
Basic earnings per share
-45.87%-0.37
-45.02%-0.34
24.53%-3.63
-269.57%-0.6846
-490.32%-1.14
-26.90%-0.2537
17.23%-0.2345
-207.98%-4.81
-4.36%-0.1852
83.52%-0.1931
Diluted earnings per share
-45.87%-0.37
-45.02%-0.34
24.53%-3.63
-269.57%-0.6846
-490.32%-1.14
-26.90%-0.2537
17.23%-0.2345
-207.98%-4.81
-4.36%-0.1852
83.52%-0.1931
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 51.73%63.82M53.38%60.07M85.54%252.1M271.13%114M85.82%56.86M34.32%42.06M-9.41%39.17M-42.75%135.87M15.71%30.72M-82.82%30.6M
Selling and administrative expenses 63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M89.53%15.26M19.36%9.29M19.74%9.68M26.78%31.12M-5.80%7.2M20.90%8.05M
-General and administrative expense 63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M89.53%15.26M19.36%9.29M19.74%9.68M26.78%31.12M-5.80%7.2M20.90%8.05M
Research and development costs 48.40%48.63M55.19%45.76M97.26%206.62M336.88%102.77M84.49%41.6M39.28%32.77M-16.11%29.49M-50.77%104.75M24.40%23.52M-86.85%22.55M
Operating profit -51.73%-63.82M-53.38%-60.07M-85.54%-252.1M-271.13%-114M-85.82%-56.86M-34.32%-42.06M9.41%-39.17M42.75%-135.87M-15.71%-30.72M82.82%-30.6M
Net non-operating interest income expense 48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M172.97%3.84M353.83%3.56M4,050.00%3.57M4.56M2.29M1.41M
Non-operating interest income 48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M172.97%3.84M353.83%3.56M4,050.00%3.57M--4.56M--2.29M--1.41M
Other net income (expense) 38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K99.32%-1K-124.68%-39K-124.07%-26K3,581.82%405K168.01%287K-243.69%-148K
Other non- operating income (expenses) 38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K99.32%-1K-124.68%-39K-124.07%-26K3,581.82%405K168.01%287K-243.69%-148K
Income before tax -51.97%-58.58M-50.80%-53.72M-80.02%-235.66M-285.35%-108.46M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M83.52%-29.34M
Income tax 125K268K00
Net income -52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M83.52%-29.34M
Net income continuous Operations -52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M83.52%-29.34M
Minority interest income
Net income attributable to the parent company -52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M83.52%-29.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M83.52%-29.34M
Basic earnings per share -45.87%-0.37-45.02%-0.3424.53%-3.63-269.57%-0.6846-490.32%-1.14-26.90%-0.253717.23%-0.2345-207.98%-4.81-4.36%-0.185283.52%-0.1931
Diluted earnings per share -45.87%-0.37-45.02%-0.3424.53%-3.63-269.57%-0.6846-490.32%-1.14-26.90%-0.253717.23%-0.2345-207.98%-4.81-4.36%-0.185283.52%-0.1931
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data